Ligand validation:5JJJ

LFA: EICOSANE

LFA is a Ligand Of Interest in 5JJJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5JJJ_LFA_A_309	33%	77%	0.187	0.956	0.29	0.6	-	-	1	0	50%	0.5
5JJJ_LFA_A_306	31%	74%	0.193	0.897	0.3	0.7	-	-	3	0	80%	0.8
5JJJ_LFA_A_307	9%	75%	0.297	0.824	0.29	0.68	-	-	0	0	80%	0.8
5JJJ_LFA_A_303	7%	78%	0.197	0.763	0.21	0.66	-	-	0	0	35%	0.35
5JJJ_LFA_A_302	5%	77%	0.217	0.726	0.18	0.72	-	-	0	0	50%	0.5
5JJJ_LFA_A_308	5%	88%	0.341	0.885	0.2	0.46	-	-	0	0	25%	0.25
5JJJ_LFA_A_304	1%	79%	0.309	0.624	0.23	0.62	-	-	0	0	50%	0.5
5JJJ_LFA_A_305	1%	74%	0.473	0.707	0.3	0.69	-	-	0	0	80%	0.8
3QAP_LFA_A_247	38%	81%	0.09	0.927	0.39	0.43	-	-	0	0	25%	0.25
5JJE_LFA_A_310	38%	83%	0.126	0.861	0.27	0.51	-	-	0	0	80%	0.8
3QDC_LFA_A_248	22%	81%	0.138	0.872	0.34	0.48	-	-	0	0	35%	19.25
4GYC_LFA_A_306	22%	73%	0.197	0.885	0.3	0.73	-	-	0	0	60%	0.6
5JJF_LFA_A_308	7%	80%	0.275	0.767	0.31	0.52	-	-	6	0	80%	0.8
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	55%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	0	70%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.